Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  methanol extraction residue of BCG
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 55 for your search:
Start Over
Phase III Adjuvant Chemotherapy with DTIC vs Chemoimmunotherapy with DTIC/MER in Stage III/IV Malignant Melanoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: UMCC-7411
Phase III Surgery and/or Chemotherapy with DRB and/or Immunotherapy with MER and Mononuclear Cell Transfusions for Hairy Cell Leukemia
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-8010
Phase III Individualized Chemotherapy of Adult Acute Leukemia Based on Predicted Outcome to Remission Induction and Maintenance Treatment
Phase: Phase III
Type: Treatment
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: MDA-DT-7995, NCI-D81-043-066
Phase III Chemotherapy with CTX/MTX/VCR/5-FU/PRED with or without BCG Immunotherapy for Breast Carcinoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: CLB-7481
Phase III Chemotherapy with ARA-C/DMN, ARA-C/TG/DMN, ARA-C/TG, or ARA-C/VCR/DM & MER-BCG Immunotherapy for Acute Myelocytic Leukemia
Phase: Phase III
Type: Treatment
Status: Completed
Age: any age
Sponsor: NCI
Protocol IDs: CLB-7521, CALGB-7521
Phase III Chemotherapy with VCR/CTX/ADR, Radiotherapy and MER-BCG Immunotherapy for Neuroblastoma, Stages III and IV
Phase: Phase III
Type: Treatment
Status: Closed
Age: 1 to 18
Sponsor: NCI
Protocol IDs: CLB-7541
Adjuvant Chemotherapy with CTX/MTX/5-FU, CTX/MTX/5-FU/VCR/PRED and MER-BCG Immunotherapy after Mastectomy for Breast Carcinoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 75
Sponsor: NCI
Protocol IDs: CLB-7581
Phase III VCR/L-ASP/PRED & DNM Induction, 6-MP/MTX/VCR/PRED Maintenance & MER-BCG for Acute Lymphocytic Leukemia
Phase: Phase III
Type: Treatment
Status: Closed
Age: 20 and over
Sponsor: NCI
Protocol IDs: CLB-7612
Phase III Chemotherapy with DNM/HU/6-MP/CTX/PRED and Immunotherapy with MER-BCG for Resistant Chronic Granulocytic Leukemia
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: CLB-7631
Phase III Chemotherapy with ADR or CTX/VCR/DTIC with or without MER-BCG Immunotherapy for Soft Tissue Sarcomas
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: CLB-7681
Phase III Chemotherapy with CTX/MTX/5-FU, CTX/5-FU/ADR, CTX/5-FU/ADR/VCR/PRED & MER-BCG Immunotherapy for Breast Carconoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: postmenopausal under 70
Sponsor: NCI
Protocol IDs: CLB-7682, CALGB-7682
Phase III MTX, ADR, CCNU, CTX, VCR Chemotherapy in Two Combinations plus Radiotherapy and MER Immunotherapy for Oat Cell Carcinoma of the Lung
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: CLB-7781, CALGB-7781
Phase III Adjuvant Immunotherapy with MER-BCG for High-Risk Stage I/II Malignant Melanoma of the Head, Neck, Extremities, and Trunk
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: YALE-HIC-1351, NCI-T83-1147D
Phase II Chemotherapy with Vindesine with or without MER-BCG for Metastatic Colorectal Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-7737
Phase II Therapy with MER-BCG plus Lithium Carbonate and Mononuclear Cell Transfusion for Oligoleukemia and Preleukemia
Phase: Phase II
Type: Supportive care
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-7908
Phase II Chemotherapy with BVDD (BLEO/VBL/DTIC/CACP) with vs without Intravenous MER-BCG for Stage IV Metastatic Melanoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-8124
Phase II Combination Chemotherapy with DAVA/DTIC plus MER Immunotherapy for Stage IV Metastatic Malignant Melanoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: over 15
Sponsor:
Protocol IDs: MDA-DT-7996R
Phase II Immunotherapy with BCG or MER-BCG for Cutaneous Metastases of Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MSKCC-7010
Phase II Combination Chemotherapy of 5-FU with MeCCNU, VCR, CACP, plus MER-BCG Immunotherapy for Advanced Colorectal Carcinoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: MAYO-701833
Phase II Chemotherapy with ADR/DTIC/ACT-D/CTX plus Adjuvant Immunotherapy with MER-BCG for Advanced Sarcoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: MAYO-741202
Phase II Radiotherapy plus VCR/ADR Chemotherapy with or without MER-BCG Immunotherapy for Squamous Cell Lung Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: MAYO-752201/03
ROAP - Rubidazone/VCR/ARA-C/PRED plus MER-BCG Immunotherapy for Acute Nonlymphocytic Leukemia
Phase: No phase specified
Type: Treatment
Status: Closed
Age: over 50
Sponsor:
Protocol IDs: MDA-DT-7635A
Chemotherapy with ROAP (RBD/VCR/ARA-C/PRED) plus Immunotherapy with MER for Acute Myelogenous Leukemia in Patients Over Age 50
Phase: No phase specified
Type: Supportive care, Treatment
Status: Closed
Age: over 50
Sponsor:
Protocol IDs: MDA-DT-7760
Combination Chemotherapy with ROAP (RBD/ARA-C/VCR/PRED), POMP (6-MP/VCR/MTX/PRED) and OAP (ARA-C/VCR/PRED) plus TG with or without MER for AML
Phase: No phase specified
Type: Treatment
Status: Closed
Age: under 60
Sponsor:
Protocol IDs: MDA-DT-7926
Bone Marrow Restoration with Lithium Carbonate and MER-BCG for Oligoleukemia and Pre-Leukemia
Phase: No phase specified
Type: Supportive care
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-8035P
Start Over